World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
150
Citations
98673
World Ranking
1146
National Ranking
121

Athol U. Wells publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Athol U. Wells sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 861 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Athol U. Wells D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Athol U. Wells sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 150 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Athol U. Wells is affiliated with Imperial College London in the United Kingdom and has an extensive publication record primarily in the field of Medicine, with a strong concentration in Pulmonary and Respiratory Medicine. Their research intersects several subfields including Physiology, Pathology and Forensic Medicine, Epidemiology, and Public Health, Environmental and Occupational Health.

Their scholarly work addresses various aspects of respiratory and interstitial lung diseases, with a notable focus on idiopathic pulmonary fibrosis, sarcoidosis, and beryllium toxicity research. The main topics covered in their research include:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Sarcoidosis and Beryllium Toxicity Research
  • Medical Imaging and Pathology Studies
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Occupational and environmental lung diseases
  • Systemic Sclerosis and Related Diseases
  • Occupational exposure and asthma

Their recent published papers illustrate the focus and breadth of their research, including:

  • "The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic" (2020), published in CHEST Journal
  • "The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society" (2020), published in Radiology
  • "Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy" (2020), published in The Lancet Respiratory Medicine
  • "ERS clinical practice guidelines on treatment of sarcoidosis" (2021), published in European Respiratory Journal
  • "Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial" (2020), published in The Lancet Respiratory Medicine

The venues in which Athol U. Wells most frequently publishes include:

  • European Respiratory Journal
  • American Journal of Respiratory and Critical Care Medicine
  • The Lancet Respiratory Medicine
  • Respirology
  • CHEST Journal

Collaborative research is a significant aspect of their work. Frequent co-authors include:

  • Vasileios Kouranos
  • Elisabetta Renzoni
  • Peter M. George
  • Maria Kokosi
  • Felix Chua

Best Publications

  • An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management

    Ganesh Raghu;Harold R. Collard;Jim J. Egan;Fernando J. Martinez

  • American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

    William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch

  • An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King

  • Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

    Ganesh Raghu;Martine Remy-Jardin;Jeffrey L. Myers;Luca Richeldi

  • Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

    Kevin R Flaherty;Athol U Wells;Kevin K Brown

  • An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline

    Ganesh Raghu;Bram Rochwerg;Yuan Zhang;Carlos A. Cuello Garcia

  • The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society

    Geoffrey D. Rubin;Christopher J. Ryerson;Linda B. Haramati;Nicola Sverzellati

  • Acute Exacerbations of Idiopathic Pulmonary Fibrosis

    Harold R. Collard;Bethany B. Moore;Kevin R. Flaherty;Kevin K. Brown

  • Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    Collard Hr;Ryerson Cj;Corte Tj;Jenkins G

  • Interstitial lung disease in systemic sclerosis: a simple staging system.

    Nicole S. L. Goh;Sujal R. Desai;Srihari Veeraraghavan;David M. Hansell

  • Idiopathic pulmonary fibrosis

    Fernando J Martinez;Harold R Collard;Annie Pardo;Ganesh Raghu

  • Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

    A U Wells;N Hirani

  • Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.

    Peter M George;Athol U Wells;R Gisli Jenkins

  • Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.

    David A Lynch;Nicola Sverzellati;William D Travis;Kevin K Brown

  • An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

    Aryeh Fischer;Katerina M. Antoniou;Kevin K. Brown;Jacques Cadranel

  • Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

    Demosthenes Bouros;Athol U Wells;Andrew G Nicholson;Andrew G Nicholson;Thomas V Colby

  • A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

    Rachel K Hoyles;Ross W Ellis;Jessica Wellsbury;Belinda Lees

  • Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.

    Tasha E. Fingerlin;Elissa Murphy;Weiming Zhang;Anna L. Peljto

  • Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.

    Athol U Wells;Sujal R Desai;Michael B Rubens;Nicole S L Goh

  • Pulmonary hypertension due to left heart diseases.

    Jean-Luc Vachiery;Yochai Adir;Joan Albert Barberà;Hunter C. Champion

Frequent Co-Authors

Toby M. Maher
Toby M. Maher University of Southern California
David M. Hansell
David M. Hansell National Institutes of Health
Andrew G. Nicholson
Andrew G. Nicholson Royal Brompton Hospital
Christopher P. Denton
Christopher P. Denton University College London
Kevin K. Brown
Kevin K. Brown National Jewish Health
Vincent Cottin
Vincent Cottin Claude Bernard University Lyon 1
Roland M. du Bois
Roland M. du Bois Imperial College London
Kevin R. Flaherty
Kevin R. Flaherty University of Michigan–Ann Arbor
Luca Richeldi
Luca Richeldi Catholic University of the Sacred Heart
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but exploring alternative career pathways, there are numerous online degree options that can launch or enhance your journey in healthcare. Many students choose accelerated programs to enter the workforce faster. For example, fastest lpn program options online allow you to become a Licensed Practical Nurse quickly, providing a valuable entry point to clinical roles.

Mental health is a growing field in the medical sector. Advanced programs such as online psych np programs help nurses specialize as Psychiatric Mental Health Nurse Practitioners, opening doors to impactful behavioral health roles.

For those drawn to healthcare leadership, consider a Master’s in Healthcare Administration. The best online mha programs can prepare you for high-level roles managing hospitals, clinics, or health systems, while the cheapest online master degree in healthcare administration offers an affordable path to advance your credentials without excessive debt.

Each of these online programs provides flexibility and unique pathways into the healthcare sector, making them great alternatives or complements to traditional medical school.

Best Scientists Citing Athol U. Wells

Trending Scientists

Recently Published Articles